Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ. | Proc Natl Acad Sci U S A | 2023 | 37155846 | PubTator, text mining | PubMed |
| Decreased SPTBN2 expression regulated by the ceRNA network is associated with poor prognosis and immune infiltration in low‑grade glioma. | Exp Ther Med | 2023 | 37153896 | PubTator, text mining | PubMed |
| Sperm morphological abnormalities in autosomal dominant polycystic kidney disease are associated with the Hippo signaling pathway via PC1. | Front Endocrinol (Lausanne) | 2023 | 37152951 | PubTator, text mining | PubMed |
| Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis. | Front Mol Biosci | 2023 | 37152902 | PubTator, text mining | PubMed |
| m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis. | Front Oncol | 2023 | 37152066 | PubTator, text mining | PubMed |
| S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development. | Int J Biol Sci | 2023 | 37151881 | PubTator, text mining | PubMed |
| Hypoxia-elicited Exosomes Promote the Chemoresistance of Pancreatic Cancer Cells by Transferring LncROR via Hippo Signaling. | J Cancer | 2023 | 37151398 | PubTator, text mining | PubMed |
| Illuminating the druggable genome through patent bioactivity data. | PeerJ | 2023 | 37151295 | PubTator, text mining | PubMed |
| The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1. | J Transl Med | 2023 | 37147639 | PubTator, text mining | PubMed |
| Oncogenic signaling-mediated regulation of chromatin during tumorigenesis. | Cancer Metastasis Rev | 2023 | 37147457 | PubTator, text mining | PubMed |
| KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. | Nat Commun | 2023 | 37147285 | PubTator, text mining | PubMed |
| Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis. | J Exp Clin Cancer Res | 2023 | 37143164 | PubTator, text mining | PubMed |
| An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer. | Front Pharmacol | 2023 | 37138852 | PubTator, text mining | PubMed |
| Prognostic value of the S100 calcium-binding protein family members in hepatocellular carcinoma. | Biosci Rep | 2023 | 37133437 | PubTator, text mining | PubMed |
| A review of signal pathway induced by virulent protein CagA of Helicobacter pylori. | Front Cell Infect Microbiol | 2023 | 37124036 | PubTator, text mining | PubMed |
| Host gene and its guest: short story about relation of long-noncoding MIR31HG transcript and microRNA miR-31. | Rep Pract Oncol Radiother | 2023 | 37122913 | PubTator, text mining | PubMed |
| GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells. | Front Pharmacol | 2023 | 37113762 | PubTator, text mining | PubMed |
| Pituitary Tumorigenesis-Implications for Management. | Medicina (Kaunas) | 2023 | 37109772 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2023 | 37108193 | PubTator, text mining | PubMed |
| Multi-organ landscape of therapy-resistant melanoma. | Nat Med | 2023 | 37106167 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=22